![Yposkesi launches LentiSure™, Lentiviral (LV) Vector production platform optimized for higher yields](https://ala.associates/wp-content/uploads/2023/04/LentiSure-official-image-with-title1-1080x675.png)
![Yposkesi launches LentiSure™, Lentiviral (LV) Vector production platform optimized for higher yields](https://ala.associates/wp-content/uploads/2023/04/LentiSure-official-image-with-title1-1080x675.png)
![Ciliatech presents groundbreaking concept in glaucoma implants, first to bypass opening anterior eye chamber](https://ala.associates/wp-content/uploads/2022/09/Ciliatech-CID-concept_Image-credit-Panacee-1080x675.jpg)
Ciliatech presents groundbreaking concept in glaucoma implants, first to bypass opening anterior eye chamber
![Lynred and Umicore co-develop next-generation thermal sensing solution for Pedestrian Autonomous Emergency Braking (PAEB)](https://ala.associates/wp-content/uploads/2022/09/RBGvsLWIR-1080x675.png)
Lynred and Umicore co-develop next-generation thermal sensing solution for Pedestrian Autonomous Emergency Braking (PAEB)
![Microlight3D releases new range of resins for 3D microprinting](https://ala.associates/wp-content/uploads/2022/06/DSCF3024-scaled-e1655191334336-1080x675.jpg)
Microlight3D releases new range of resins for 3D microprinting
![Nosopharm and GNA Now announce positive results for the late preclinical development of the first-in-class antibiotic NOSO-502](https://ala.associates/wp-content/uploads/2022/06/Nosopharm-RD-1080x675.jpg)
Nosopharm and GNA Now announce positive results for the late preclinical development of the first-in-class antibiotic NOSO-502
![Lynred launches two multispectral linear array infrared detectors for future Earth observation mission applications](https://ala.associates/wp-content/uploads/2022/06/Copyright-Lynred-PEGA-@LYNRED.jpg)
Lynred launches two multispectral linear array infrared detectors for future Earth observation mission applications
![Kayentis launches fully integrated platform for decentralized clinical trials](https://ala.associates/wp-content/uploads/2022/03/Kayentis-Clinform-solution.jpg)
Kayentis launches fully integrated platform for decentralized clinical trials
![Oculis Strengthens Leading Ophthalmology Pipeline by In-Licensing Neuroprotective Drug Candidate for Glaucoma from Accure Therapeutics](https://ala.associates/wp-content/uploads/2022/02/ngcd-laurent-0012--472x675.jpeg)
Oculis Strengthens Leading Ophthalmology Pipeline by In-Licensing Neuroprotective Drug Candidate for Glaucoma from Accure Therapeutics
![Abzena, Alira Health and Oncodesign launch DRIVE-Biologics to support access to specialist services from discovery to clinical development for oncology and inflammation](https://ala.associates/wp-content/uploads/2022/02/Oncodesign-antibodies-1080x675.jpg)
Abzena, Alira Health and Oncodesign launch DRIVE-Biologics to support access to specialist services from discovery to clinical development for oncology and inflammation
![Lynred boosts thermal sensitiviity across range of 12-micron infrared detectors](https://ala.associates/wp-content/uploads/2021/11/ATTOcomm-1080x675.png)